🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very proud of being part of this great team and proud of the work that we are doing. Thank you Gerhard Gruender, thank you MIND Foundation for the opportunity and for creating this important space for exchange in this diverse field!

Heute Einladung von Prof. Alexandra Philipsen nach Bonn zum spannenden Herbstsymposium; gemeinsam mit Profs. @Karl_Broich, Gerhard Gruender, Nils Kroemer und Dieter Braus Zukunft der Psychotherapie, Psychopharmakologie, von DiGAs & Stimulationsverfahren visioniert

Thank you for posting this video here. Just to let you know that we will soon start an outpatient clinic at Zentralinstitut für Seelische Gesundheit for people who want to withdraw their psychotropic medication or have trouble with withdrawal or post-withdrawal syndromes including #PSSD.

My talk at the opening of the INSIGHT conference 2023 in Berlin: Psychedelics in Psychiatry: an Incremental Step Forward or a Paradigm Sh... youtu.be/u3ZEySAUuPs?si… via YouTube

How high must the blood concentration 🩸 of an #antipsychotic be for the D2 receptors to be optimally occupied? 🧠 Fantastic work by the amazing Xenia Hart, PhD. Proud to have contributed to this clinically relevant overview. Gerhard Gruender Zentralinstitut für Seelische Gesundheit pubmed.ncbi.nlm.nih.gov/38018857/

Zum Ende des Jahres: ist die Therapie mit Psychedelika bloß Trend und Hype? Unser Team hat Risiko, Nutzen und, warum der aktuelle Forschungsstand noch nicht ausreichend ist, zusammengefasst link.springer.com/article/10.100… LauraKärtner @leame22 Christian Schmitz Gerhard Gruender Dennis Scharf

Michael Haichin Great summary! Gerhard Gruender's article "Treatment With Psychedelics Is Psychotherapy: Beyond Reductionism" can be considered another response to Goodwin's commentary, although it was published in a different journal @TheLancetPsych Free access here: authors.elsevier.com/c/1iFBe7tf1d51…

Much about the pharmacokinetics of clozapine is poorly understood: Do levels in the toxic reference range always mean that we should stop the drug? Here we describe a case where an acute phase protein could be the actual cause. More studies needed. Xenia Hart, PhD Gerhard Gruender

Ein kurzer Einblick vom Spiegel in unsere Arbeit in der Episode-Studie. Reflektierter und ausgeglichener Beitrag! Zentralinstitut für Seelische Gesundheit @tomislavmajic Gerhard Gruender youtu.be/pffeFfYD3AM?si…

25/25 Many thanks to the team of authors (including core APT faculty & APT participants) Henrik Jungaberle Gerhard Gruender @leame22 Aaron D. Cherniak Ricarda Evens, J Beck, H Rutrecht & C Schmidt. Also truly grateful to the very (!) constructive peer reviewers. doi.org/10.1177/026988…

Had a great time at #icpr2024 presenting our literature review of subjects that did not report any (or almost any) subjective effects despite administration of very high doses of serotonergic psychedelics. If you know or have heard of similar cases, hit me up 🙂🍄

Very excited that our first paper from our ketamine study has been published in Frontiers. Gerhard Gruender I have prepared a small thread to contextualize the study results. frontiersin.org/journals/psych…

Mit meinem Vortrag zur psychedelikagestützten Psychotherapie ab ca. 1:22 h. youtu.be/WoL-WPj3YX0?si…

EPIsoDE-Abschlusssymposium in Mannheim linkedin.com/pulse/episode-… via LinkedIn

How can dopamine supersensitivity be examined in humans? In our work led by the meticulous Christian Schmitz we show that it is possible & that the availability of D2receptors is negatively associated with dopaminergic induced cerebral perfusion Gerhard Gruender sciencedirect.com/science/articl…

Moritz Spangemacher Lea Mertens We hope this is the first ACNP of many for you ☺️

Glad to be at #ACNP2024 in Phoenix with Moritz Spangemacher and Gerhard Gruender! On Monday, I will be presenting the results of our episode trial in the session „Psychedelic-assisted Psychotherapy: From preclinical mechanisms to clinical applications“. Come and join our discussion :)